Search

Raymond J. Henley Iii

Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 2899, 1629, 1614, 1621
Total Applications
4324
Issued Applications
3034
Pending Applications
603
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9757474 [patent_doc_number] => 20140288176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'ENANTIOMERS OF 2-HYDROXY DERIVATIVES OF FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 14/349962 [patent_app_country] => US [patent_app_date] => 2012-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16488 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349962 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/349962
Enantiomers of 2-hydroxy derivatives of fatty acids Oct 7, 2012 Issued
Array ( [id] => 9875413 [patent_doc_number] => 08962681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Use of aminoacetonitrile derivatives against endoparasites' [patent_app_type] => utility [patent_app_number] => 14/351945 [patent_app_country] => US [patent_app_date] => 2012-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8636 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351945 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/351945
Use of aminoacetonitrile derivatives against endoparasites Oct 7, 2012 Issued
Array ( [id] => 8932669 [patent_doc_number] => 08492368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Nasal delivery mechanism for prophylactic and post-acute use of progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries' [patent_app_type] => utility [patent_app_number] => 13/645881 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16256 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13645881 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/645881
Nasal delivery mechanism for prophylactic and post-acute use of progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries Oct 4, 2012 Issued
Array ( [id] => 9212651 [patent_doc_number] => 20140011828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/644241 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13561 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644241 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/644241
Forms of rifaximin and uses thereof Oct 2, 2012 Issued
Array ( [id] => 8659458 [patent_doc_number] => 20130040288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Biological Specimen Collection and Transport System and Method of Use' [patent_app_type] => utility [patent_app_number] => 13/632272 [patent_app_country] => US [patent_app_date] => 2012-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15991 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13632272 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/632272
Biological specimen collection and transport system and method of use Sep 30, 2012 Issued
Array ( [id] => 10013083 [patent_doc_number] => 09056086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/622120 [patent_app_country] => US [patent_app_date] => 2012-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17709 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622120 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/622120
Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof Sep 17, 2012 Issued
Array ( [id] => 8977393 [patent_doc_number] => 20130210822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Compositions for Modulating a Kinase Cascade and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/614063 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 44682 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614063 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/614063
Compositions for modulating a kinase cascade and methods of use thereof Sep 12, 2012 Issued
Array ( [id] => 9616886 [patent_doc_number] => 20140206743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'USE OF 3-(R)-[3-(2-METHOXYPHENYLTHIO)-2-(S)-METHYLPROPYL]AMINO-3,4-DIHYDRO- 2H-1,5-BENZOXATHIEPINE FOR TREATING CANCER AND IN PARTICULAR FOR PREVENTING AND/OR TREATING CANCER METASTASES' [patent_app_type] => utility [patent_app_number] => 14/342011 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3989 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342011 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342011
Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases Sep 11, 2012 Issued
Array ( [id] => 9771207 [patent_doc_number] => 20140294870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Autoimmune and Inflammatory Disorder Therapy' [patent_app_type] => utility [patent_app_number] => 14/343416 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343416 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/343416
Autoimmune and inflammatory disorder therapy Sep 6, 2012 Issued
Array ( [id] => 9616911 [patent_doc_number] => 20140206768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'CHOLINE SALT OF AN ANTI-INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/241306 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4099 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241306 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/241306
Choline salt of an anti-inflammatory substituted cyclobutenedione compound Aug 30, 2012 Issued
Array ( [id] => 10947031 [patent_doc_number] => 20140350052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Methods and Compositions for Reducing Serum Levels of Immunoglobulin E (IGE)' [patent_app_type] => utility [patent_app_number] => 14/241388 [patent_app_country] => US [patent_app_date] => 2012-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10354 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241388 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/241388
Methods and compositions for reducing serum levels of immunoglobulin E (IgE) Aug 28, 2012 Issued
Array ( [id] => 10974345 [patent_doc_number] => 20140377380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEPHROGENIC DIABETES INSIPIDUS' [patent_app_type] => utility [patent_app_number] => 14/241720 [patent_app_country] => US [patent_app_date] => 2012-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41564 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241720 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/241720
Methods and compositions for treating nephrogenic diabetes insipidus Aug 28, 2012 Issued
Array ( [id] => 8496453 [patent_doc_number] => 20120295861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Combination Therapy With Organic Arsenicals' [patent_app_type] => utility [patent_app_number] => 13/559036 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4372 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13559036 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/559036
Combination Therapy With Organic Arsenicals Jul 25, 2012 Abandoned
Array ( [id] => 9350320 [patent_doc_number] => 08669211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Methods for measuring enhancement in the quality of life of an animal' [patent_app_type] => utility [patent_app_number] => 13/556925 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17101 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13556925 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/556925
Methods for measuring enhancement in the quality of life of an animal Jul 23, 2012 Issued
Array ( [id] => 10579833 [patent_doc_number] => 09301945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation' [patent_app_type] => utility [patent_app_number] => 14/234033 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6715 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234033 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/234033
Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation Jul 18, 2012 Issued
Array ( [id] => 10882505 [patent_doc_number] => 08906885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Treating cancer with HSP90 inhibitory compounds' [patent_app_type] => utility [patent_app_number] => 14/131183 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 26508 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131183 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/131183
Treating cancer with HSP90 inhibitory compounds Jul 8, 2012 Issued
Array ( [id] => 8465773 [patent_doc_number] => 20120270941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'TOPICAL APPLICATION OF TRAVOPROST FOR COMBATING HAIR LOSS' [patent_app_type] => utility [patent_app_number] => 13/543289 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8172 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543289 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/543289
Topical application of travoprost for combating hair loss Jul 5, 2012 Issued
Array ( [id] => 8995037 [patent_doc_number] => 08518921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Compositions and methods for inducing bone growth and inhibiting bone loss' [patent_app_type] => utility [patent_app_number] => 13/539591 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8255 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539591 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/539591
Compositions and methods for inducing bone growth and inhibiting bone loss Jul 1, 2012 Issued
Array ( [id] => 9518869 [patent_doc_number] => 20140155362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'BHQ-CONJUGATES, AND RELATED COMPOUNDS, METHODS OF MAKING THE SAME, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/117058 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16720 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117058 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117058
BHQ-CONJUGATES, AND RELATED COMPOUNDS, METHODS OF MAKING THE SAME, AND METHODS OF USE THEREOF Jun 27, 2012 Abandoned
Array ( [id] => 9464007 [patent_doc_number] => 20140128434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'METHOD OF ADMINISTRATION AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/128007 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27236 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128007 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/128007
Method of administration and treatment Jun 27, 2012 Issued
Menu